Newly Convicted 'Pharma Bro' Martin Shkreli Shined a Light on Pharma's Biggest Scandals
Newly Convicted 'Pharma Bro' Martin Shkreli Shined a Light on Pharma's Biggest Scandals
Trump responds to critics who want H.R. McMaster fired
President Donald Trump has reaffirmed his support of Gen. H.R. McMaster, his national security...
North Korea’s ICBM tests may be a deception tactic to hide a much more capable threat
A top missile analyst says the ICBMs North Korea shows off may be propaganda that has fooled...
Russian deputy minister blacklisted in new EU sanctions over Siemens turbines to Crimea
The European Union on Friday imposed sanctions on three more Russians, including Deputy Energy Minister Andrei Cherezov, and three Russian companies over the delivery of Siemens' turbines to Moscow-annexed Crimea. Moscow criticized the EU's decision as an unfriendly and groundless act and said it reserved the right to take retaliatory steps. The EU first introduced sanctions on Russia after the 2014 military takeover of the Black Sea peninsula from Kiev, and stepped them up repeatedly as Moscow then backed separatist unrest in the east of Ukraine.
Documents released on Lynch’s tarmac meeting with Bill Clinton
American Center for Law and Justice's Jordan Sekulow discusses the newly released documents on Loretta Lynch and Bill Clinton's tarmac meeting.
Paul Ryan pushed back on Jeff Sessions’ veiled threat to journalists
House Speaker Paul Ryan criticized Attorney General Jeff Sessions' insinuation that the Justice...
These Analysts Say It’s Not Time to Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX)
Is Teva Pharmaceutical a Falling Knife to Catch After Plunging over 30%? This week turned out to be a nightmare for shareholders of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after the drug maker missed earnings expectations, lowered its guidance and approved a dividend cut, sending shares tumbling nearly 33%. This is appropriate, in our view, given higher than expected generic drug price erosion and deteriorating economic conditions in Venezuela.